(Bloomberg) -- U.S. Chief Justice John Roberts cleared the way for Dr. Reddy’s Laboratories Ltd. to resume selling a generic version of Indivior Plc’s opioid addiction treatment Suboxone Film.

Rejecting arguments from Indivior, Roberts left in force a ruling, set to take effect Tuesday, that lets Dr. Reddy’s put the generic drug on market. Indivior said Dr. Reddy’s should wait until the high court considers whether to hear an appeal in the case.

To contact the reporters on this story: Greg Stohr in Washington at gstohr@bloomberg.net;Susan Decker in Washington at sdecker1@bloomberg.net

To contact the editor responsible for this story: Joe Sobczyk at jsobczyk@bloomberg.net

©2019 Bloomberg L.P.